101 related articles for article (PubMed ID: 8315600)
21. IgA and IgG antibodies against surface antigens of Pseudomonas aeruginosa in sputum and serum from patients with cystic fibrosis.
Schiøtz PO; Høiby N; Permin H; Wiik A
Acta Pathol Microbiol Scand C; 1979 Jun; 87C(3):229-33. PubMed ID: 113981
[TBL] [Abstract][Full Text] [Related]
22. Human salivary aggregation in Streptococcus intermedius type g strains: relationship with IgA.
Yamaguchi T
FEMS Immunol Med Microbiol; 2004 Jun; 41(2):101-7. PubMed ID: 15145453
[TBL] [Abstract][Full Text] [Related]
23. Can secretory immunoglobulin A in saliva predict a change in lung infection status in patients with cystic fibrosis? A prospective pilot study.
Alanin MC; Pressler T; Aanaes K; Ekstrøm CT; Skov M; Johansen HK; Nielsen KG; von Buchwald C; Høiby N
Health Sci Rep; 2018 Aug; 1(8):e52. PubMed ID: 30623088
[TBL] [Abstract][Full Text] [Related]
24. Genotypic and phenotypic relatedness of Pseudomonas aeruginosa isolates among the major cystic fibrosis patient cohort in Italy.
Cigana C; Melotti P; Baldan R; Pedretti E; Pintani E; Iansa P; De Fino I; Favari F; Bergamini G; Tridello G; Cirillo DM; Assael BM; Bragonzi A
BMC Microbiol; 2016 Jul; 16(1):142. PubMed ID: 27400750
[TBL] [Abstract][Full Text] [Related]
25. Immunoglobulin A antibodies against Pseudomonas aeruginosa in the tear fluid of contact lens wearers.
Cheng KH; Spanjaard L; Rutten H; Dankert J; Polak BC; Kijlstra A
Invest Ophthalmol Vis Sci; 1996 Sep; 37(10):2081-8. PubMed ID: 8814147
[TBL] [Abstract][Full Text] [Related]
26. Relationship between cystic fibrosis respiratory tract bacterial communities and age, genotype, antibiotics and Pseudomonas aeruginosa.
Klepac-Ceraj V; Lemon KP; Martin TR; Allgaier M; Kembel SW; Knapp AA; Lory S; Brodie EL; Lynch SV; Bohannan BJ; Green JL; Maurer BA; Kolter R
Environ Microbiol; 2010 May; 12(5):1293-303. PubMed ID: 20192960
[TBL] [Abstract][Full Text] [Related]
27. Respiratory tract colonization with Pseudomonas aeruginosa in cystic fibrosis: correlations between anti-Pseudomonas aeruginosa antibody levels and pulmonary function.
Winnie GB; Cowan RG
Pediatr Pulmonol; 1991; 10(2):92-100. PubMed ID: 1903199
[TBL] [Abstract][Full Text] [Related]
28. Pseudomonas aeruginosa in the oral cavity and sputum of patients with cystic fibrosis.
Komiyama K; Tynan JJ; Habbick BF; Duncan DE; Liepert DJ
Oral Surg Oral Med Oral Pathol; 1985 Jun; 59(6):590-4. PubMed ID: 3925406
[TBL] [Abstract][Full Text] [Related]
29. Anti-neutrophil cytoplasmic antibodies (ANCA) against bactericidal/permeability-increasing protein (BPI) and cystic fibrosis lung disease.
Mahadeva R; Dunn AC; Westerbeek RC; Sharples L; Whitehouse DB; Carroll NR; Ross-Russell RI; Webb AK; Bilton D; Lomas DA; Lockwood CM
Clin Exp Immunol; 1999 Sep; 117(3):561-7. PubMed ID: 10469063
[TBL] [Abstract][Full Text] [Related]
30. Inflammation in cystic fibrosis airways: relationship to increased bacterial adherence.
Scheid P; Kempster L; Griesenbach U; Davies JC; Dewar A; Weber PP; Colledge WH; Evans MJ; Geddes DM; Alton EW
Eur Respir J; 2001 Jan; 17(1):27-35. PubMed ID: 11307750
[TBL] [Abstract][Full Text] [Related]
31. Pseudomonas aeruginosa and Periodontal Pathogens in the Oral Cavity and Lungs of Cystic Fibrosis Patients: a Case-Control Study.
Rivas Caldas R; Le Gall F; Revert K; Rault G; Virmaux M; Gouriou S; Héry-Arnaud G; Barbier G; Boisramé S
J Clin Microbiol; 2015 Jun; 53(6):1898-907. PubMed ID: 25854483
[TBL] [Abstract][Full Text] [Related]
32. Upper aero-digestive contamination by Pseudomonas aeruginosa and implications in Cystic Fibrosis.
Rivas Caldas R; Boisramé S
J Cyst Fibros; 2015 Jan; 14(1):6-15. PubMed ID: 24933711
[TBL] [Abstract][Full Text] [Related]
33. Assessment of airway microbiota and inflammation in cystic fibrosis using multiple sampling methods.
Zemanick ET; Wagner BD; Robertson CE; Stevens MJ; Szefler SJ; Accurso FJ; Sagel SD; Harris JK
Ann Am Thorac Soc; 2015 Feb; 12(2):221-9. PubMed ID: 25474078
[TBL] [Abstract][Full Text] [Related]
34. Relative increase in IgG antibodies to Pseudomonas aeruginosa 60-kDa GroEL in prediabetic patients with cystic fibrosis.
Jensen P; Johansen HK; Lanng S; Høiby N
Pediatr Res; 2001 Mar; 49(3):423-8. PubMed ID: 11228271
[TBL] [Abstract][Full Text] [Related]
35. Pseudomonas aeruginosa adherence to remodelling respiratory epithelium.
de Bentzmann S; Roger P; Puchelle E
Eur Respir J; 1996 Oct; 9(10):2145-50. PubMed ID: 8902481
[TBL] [Abstract][Full Text] [Related]
36. Ciprofloxacin during upper respiratory tract infections to reduce Pseudomonas aeruginosa infection in paediatric cystic fibrosis: a pilot study.
Connett GJ; Pike KC; Legg JP; Cathie K; Dewar A; Foote K; Harris A; Faust SN
Ther Adv Respir Dis; 2015 Dec; 9(6):272-80. PubMed ID: 26341118
[TBL] [Abstract][Full Text] [Related]
37. Pseudomonas aeruginosa infection in cystic fibrosis. Bactericidal effect of serum from normal individuals and patients with cystic fibrosis on P. aeruginosa strains from patients with cystic fibrosis or other diseases.
Holby N; Olling S
Acta Pathol Microbiol Scand C; 1977 Apr; 85(2):107-14. PubMed ID: 404841
[TBL] [Abstract][Full Text] [Related]
38. Microbial ecology and adaptation in cystic fibrosis airways.
Yang L; Jelsbak L; Molin S
Environ Microbiol; 2011 Jul; 13(7):1682-9. PubMed ID: 21429065
[TBL] [Abstract][Full Text] [Related]
39. [Chronic Pseudomonas aeruginosa airway colonization in cystic fibrosis patients : Prevention concepts].
Dittrich AM
Internist (Berl); 2017 Nov; 58(11):1133-1141. PubMed ID: 28963697
[TBL] [Abstract][Full Text] [Related]
40. Pseudomonas colonization in cystic fibrosis. A study of 160 patients.
Kulczycki LL; Murphy TM; Bellanti JA
JAMA; 1978 Jul; 240(1):30-4. PubMed ID: 96277
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
